Altruist Biologics introduces Altru-CON, a high-concentration formulation platform to speed up biologics development

Join Pharma | Login

	Editorial


	DEFINITION ON OTC DRUGS
	Wednesday, March 4, 2026
	A robust regulatory framework for over-the-counter (OTC) medicines has been long overdue in the country. It is almost nine years since the Union Health Ministry constituted a subcommittee on the issue.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Altruist Biologics introduces Altru-CON, a high-concentration formulation platform to speed up biologics development
17:30 [IST]	ASG Eye Hospital launches advanced ocular oncology services
17:15 [IST]	CM Yogi Adityanath inaugurates KDSG Super Speciality Hospital in Greater Noida, operated by Ajeenkya DY Patil Healthcare
17:00 [IST]	MACC Fund partners with Versiti Blood Research Institute; commits $11.5 million to propel paediatric cancer research
16:30 [IST]	Alembic Pharma announces first prescription sale of Pivya following US commercial launch
16:00 [IST]	Missouri court grants preliminary approval of Roundup class settlement to resolve current and future claims

more news >>

TOP NEWS


08:00 [IST]	Indian pharma exporters brace for delays as Middle East conflict disrupts cargo routes
08:00 [IST]	Nationwide outrage as pharmacists oppose proposal to allow PACS to function without pharmacists
08:00 [IST]	KCDA asks state FDA to clarify on videography of outlets by licensing authority under its geo-tagging order
08:00 [IST]	Bulk drug and intermediates exports grew over 4.6% in first nine months of FY26
08:00 [IST]	Cold Chain Leaders Conference on March 10 to usher in next decade of temperature-controlled logistics
08:00 [IST]	US-Israel-Iran conflict creates severe impact on pharma supply chains: Experts

more news >>

YESTERDAY'S NEWS


17:40 [IST]	Apollo Hospitals, Hyderabad clinical study notes robotic myomectomy to safeguard fertility and reproductive choices
17:20 [IST]	Cetaphil raises the bar with its innovation, ‘Healthy Renew’ range in India targeted at anti-aging solution seekers
13:45 [IST]	Biocon Academy launches Syngene IBAB Certificate Programme in artificial intelligence in life sciences
12:50 [IST]	Archimedis Digital report highlights AI-led automation takes centre stage in pharma
12:40 [IST]	Physicians Committee for Responsible Medicine notes Karnataka’s 18% of urban children are obese, raising health concerns
12:25 [IST]	Haryana DCA seizes large stocks of restricted drugs and MTP kits in joint raids

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

iguratimod 25 mg tablet nebivolol 5 mg +telmisartan 40 mg tab hydroxyzine 25 mg oint methyl salicylate 450 gm clindamycin 100 mg + clotrimazole 200 mg etc...

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers